Dr. William Carson Explains Why Clinical Trials Are Safe for Black Participants

Dr. William Carson, the former CEO of Otsuka, underscores a chronic obstacle in healthcare: recruiting Black Americans for clinical trials remains as challenging now as it was two decades ago. This hesitancy often arises from fears, historical betrayals, and a lack of clarity regarding trial processes. Dr. Carson seeks to clarify misconceptions and highlight the rewards of participation. He advocates for a change in mindset, urging individuals to “run to the front of the line.” Participants receive comprehensive health assessments, which frequently reveal undiagnosed conditions. Moreover, they may access groundbreaking treatments ahead of market availability. Despite the shadow of the Tuskegee Syphilis Study, Dr. Carson emphasizes the importance of informed consent today, ensuring participants are well-informed about trial specifics. Despite safeguards, recruitment of African Americans remains a persistent challenge. He expresses frustration at misconceptions surrounding experimentation, pressing for a transformation in understanding to encourage participation and build trust in clinical studies.